Inactive Instrument

Company Mera Pharmaceuticals, Inc. Other OTC

Equities

MRPI

US58732R1032

Biotechnology & Medical Research

Business Summary

Mera Pharmaceuticals, Inc. is a marine biotechnology company. The Company focuses on photobioreactor technology and owns intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The Company manufactures natural astaxanthin from Haematococcus pluvialis microalgae. Through its research and development, the Company has formulated AstaFactor, an astaxanthin supplement with antioxidant and anti-inflammatory activity, which is available in three formulations, such as rejuvenating formula, sports formula and salmon essentials, such as natural astaxanthin combined with a blend of fish and salmon oil. The Company also produces sea salt products, such as gourmet salt and nigari. The gourmet salt includes Hawaiian Furikake, Hawaiian Furikake refillable grinder, Kona Sea Salt, Kona Sea Salt flake salt case, Kona Sea Salt grinder and Kona Sea Salt grinder case. The Company offers nigari in sizes ranging from one gallon to 250 gallons.

Sales per Business

USD in Million2009Weight2010Weight Delta
Natural Products
100.0 %
1 100.0 % 0 100.0 % -51.78%

Sales per region

USD in Million2009Weight2010Weight Delta
Global
100.0 %
1 100.0 % 0 100.0 % -51.78%

Managers

Managers TitleAgeSince
President 57 21-03-16

Members of the board

Members of the board TitleAgeSince
President 57 21-03-16
Director/Board Member 60 21-03-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 974 0 0 99.91 %
Stock B 1 557,799,676 557,299,676 ( 99.91 %) 500,000 ( 0.0896 %)
Stock C 0 80 0 0

Shareholders

NameEquities%Valuation
136 13.60 % - $
136 13.60 % - $

Company contact information

Mera Pharmaceuticals, Inc.

8275 South Eastern Avenue Suite 200

89123, Las Vegas

+

http://www.merapharma.com
address Mera Pharmaceuticals, Inc.(MRPI)
  1. Stock Market
  2. Equities
  3. MRPI Stock
  4. MRPI Stock
  5. Company Mera Pharmaceuticals, Inc.